Ingmar Bruns: Biotech & Pharma Executive, Hematology & Oncology, Leadership
Description
In this episode, our guest is Dr. Ingmar Bruns, M.D., Ph.D., a pioneer in biotech leadership and hematologist/oncologist. Dr Bruns is the Executive VP and CMO at Trillium Therapeutics Inc., a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We discuss Ingmar's breadth of experience in academia, where he studied medicine at both the Medical University of Vienna, as well as the Universität zu Lübeck, He then spent many years at both the University of Düsseldorf and the Albert Einstein College of Medicine.
We discuss a variety of topics including Ingmar’s successes and mistakes, drug development, golden rules for biotechs, as well as fundraising in the life science industry. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Dr. Ingmar Bruns
LinkedIn: https://www.linkedin.com/in/ingmar-bruns-9abb5446/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
12:12 Key Accomplishments and Reflections
20:50 Persistence in Drug Development
27:52 Identifying Differentiators in Biotechs
38:00 Communicating with Investors
53:17 Traits of Effective Leadership
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Oncology #Hematology
Hosted on Acast. See acast.com/privacy for more information.
United States
